Issue of Equity / Admission to Trading

Summary by AI ^BETAClose X

Cranswick plc has announced the issuance and admission to trading of 4,792 Ordinary Shares of 10p each, which were allotted to satisfy options under employee share plans. These new shares, admitted to the London Stock Exchange's Main Market, are fully fungible with existing ordinary shares. Following this issuance, the total number of ordinary shares in issue has increased to 54,305,147. This notification covers the period from May 9, 2026, to July 3, 2026.

Disclaimer*

Cranswick PLC

06 July 2026

Cranswick plc

('Cranswick' or the 'Company')

Issue of Equity/Admission to Trading

The Company announces that it issued and allotted 4,792 Ordinary Shares of 10p each ("New Ordinary Shares") for the purposes of satisfying options granted under the rules of the Cranswick 2023 Save As You Earn Plan and the Cranswick 2018 Long Term Incentive Plan. The New Ordinary Shares were admitted to trading under existing block admissions.

This notification is made under PRM 1.6.4 and covers the period from 9 May 2026 to 3 July 2026. The table below provides further details.

1a	Name of issuer	Cranswick plc
1b	Legal entity identifier (LEI) of issuer	549300LDZLPU51XOSK43
2	Regulated market	London Stock Exchange (XLON); Main Market
3	Name, type and ISIN of securities	Ordinary shares of 10p each ISIN: GB0002318888
4	Number of further securities admitted to trading covered by this notification	4,792
5	Total number of securities admitted to trading following further issuance	54,305,147
6	Fungibility	Fully fungible with existing ordinary shares
7	Date of issuance and admission to trading	Between 9 May 2026 and 3 July 2026
8	Prospectus information	N/A

For more information please contact:

Steven Glover, Cranswick plc, Tel: +44 (0) 1482 275 000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END